Review



cd8α microbeads  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Miltenyi Biotec cd8α microbeads
    Cd8α Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+microbeads/StraightFrom+Spleen+CD8a+MicroBead+Kit%2C+mouse/pm40523938-321-20-22
    Average 93 stars, based on 1 article reviews
    cd8α microbeads - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    Single Cell:

    Article Title: A nanovaccine targeting cancer stem cells and bulk cancer cells for postoperative cancer immunotherapy.
    Article Snippet: Residual cancer stem-like cells (CSCs) can cause tumour recurrence within a narrow margin around the initial tumour resection lesion, increasing the risk of post-surgical relapse and incurability.. Currently, there are no efficient strategies for tracking and eradicating CSCs.. Here we propose a nanovaccine strategy, called NICER, based on a nanovesicle system integrating CSC-specific antigen display and epigenetic nano-regulator encapsulation with a dendritic-cell-targeting aptamer, to simultaneously eradicate CSCs and bulk tumour cells.

    Suspension:

    Article Title: A nanovaccine targeting cancer stem cells and bulk cancer cells for postoperative cancer immunotherapy.
    Article Snippet: Residual cancer stem-like cells (CSCs) can cause tumour recurrence within a narrow margin around the initial tumour resection lesion, increasing the risk of post-surgical relapse and incurability.. Currently, there are no efficient strategies for tracking and eradicating CSCs.. Here we propose a nanovaccine strategy, called NICER, based on a nanovesicle system integrating CSC-specific antigen display and epigenetic nano-regulator encapsulation with a dendritic-cell-targeting aptamer, to simultaneously eradicate CSCs and bulk tumour cells.

    Isolation:

    Article Title: A nanovaccine targeting cancer stem cells and bulk cancer cells for postoperative cancer immunotherapy.
    Article Snippet: Residual cancer stem-like cells (CSCs) can cause tumour recurrence within a narrow margin around the initial tumour resection lesion, increasing the risk of post-surgical relapse and incurability.. Currently, there are no efficient strategies for tracking and eradicating CSCs.. Here we propose a nanovaccine strategy, called NICER, based on a nanovesicle system integrating CSC-specific antigen display and epigenetic nano-regulator encapsulation with a dendritic-cell-targeting aptamer, to simultaneously eradicate CSCs and bulk tumour cells.



    Similar Products

    95
    Miltenyi Biotec rat cd8a microbeads
    Senescence-associated GZMK⁺CD8⁺ T cells exhibit significant interactions with SS acinar cells. (A) UMAP plot showing the re-annotation and subclassification of T/NK cell populations into 14 distinct subsets from labial gland samples. (B) Bar graph displaying the proportional composition of T cell subsets in young and elderly SS patients and age- and sex-matched HCs, highlighting the increased proportion of GZMK⁺CD8⁺ T cells in SS patients. (C) The key markers associated with different T cell subsets in SS and HC groups. (D) Boxplot showing the proportion of GZMK⁺CD8⁺ T cells in the young and elderly SS groups compared to young and elderly HC groups, with the highest abundance observed in the elderly SS group. (E) Volcano plot of DEGs in GZMK⁺CD8⁺ T cells from SS patients compared to HCs, showing significantly upregulated functional genes in SS. (F) Boxplots showing the expression levels of GZMK in GZMK⁺CD8⁺ T cells from young and elderly SS patients and HCs, with significantly higher expression in SS groups, especially in the elderly SS group. (G) CellChat analysis of intercellular communication between GZMK⁺CD8⁺ T cells and various resident tissue cell types in labial glands, highlighting significant interactions with acinar cells. (H) Top 15 ligand-receptor pairs involved in the interaction between GZMK⁺CD8⁺ T cells and acinar cells, demonstrating the close communication between these cell types.
    Rat Cd8a Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+microbeads/CD8a+MicroBeads%2C+rat/pmc13685753-128-9-13
    Average 95 stars, based on 1 article reviews
    rat cd8a microbeads - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec mouse cd11c microbeads ultrapure
    Senescence-associated GZMK⁺CD8⁺ T cells exhibit significant interactions with SS acinar cells. (A) UMAP plot showing the re-annotation and subclassification of T/NK cell populations into 14 distinct subsets from labial gland samples. (B) Bar graph displaying the proportional composition of T cell subsets in young and elderly SS patients and age- and sex-matched HCs, highlighting the increased proportion of GZMK⁺CD8⁺ T cells in SS patients. (C) The key markers associated with different T cell subsets in SS and HC groups. (D) Boxplot showing the proportion of GZMK⁺CD8⁺ T cells in the young and elderly SS groups compared to young and elderly HC groups, with the highest abundance observed in the elderly SS group. (E) Volcano plot of DEGs in GZMK⁺CD8⁺ T cells from SS patients compared to HCs, showing significantly upregulated functional genes in SS. (F) Boxplots showing the expression levels of GZMK in GZMK⁺CD8⁺ T cells from young and elderly SS patients and HCs, with significantly higher expression in SS groups, especially in the elderly SS group. (G) CellChat analysis of intercellular communication between GZMK⁺CD8⁺ T cells and various resident tissue cell types in labial glands, highlighting significant interactions with acinar cells. (H) Top 15 ligand-receptor pairs involved in the interaction between GZMK⁺CD8⁺ T cells and acinar cells, demonstrating the close communication between these cell types.
    Mouse Cd11c Microbeads Ultrapure, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+microbeads/CD8a%2B+T+Cell+Isolation+Kit%2C+mouse/pm42950826-253-292-296
    Average 97 stars, based on 1 article reviews
    mouse cd11c microbeads ultrapure - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec macs cd8α ly 2 microbead magnetic cell sorting system
    A. Flow cytometry of B16-F10, B16-(AIRE-KO), and B16-(AIRE) tumor cells labelled with the AF6-88.5 antibody which recognizes the H-2K b MHC class I molecule. Mean values represent %H-2K b+ of three separate biological triplicates and error bars represent standard deviation of the mean. B. Flow cytometry of B16-OVA, B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) tumor cells labelled with the 25-D1.16 antibody which recognizes the H-2K b MHC class I molecule bound to the OVA-derived peptide SIINFEKL (K b -SIINFEKL). (See Supplemental Figure 1E for gating scheme). Mean values represent %H-2K b -SIINFEKL + of three separate biological triplicates and error bars represent standard deviation of the mean. C/D. The experiment of B. was repeated with the B16-OVA, B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) tumor cells being pre-treated for 24 hours with 50 U of rIFN-γ (to increase surface expression of H-2K b MHC class I molecules) ( C ) or with 50 U of rIFN-γ and 1 μg/mL of SIINFEKL peptide ( D ) prior to quantification of surface-expressed H-2K b -SIINFEKL by flow cytometry. Mean values represent %H-2K b -SIINFEKL + of three separate biological triplicates and error bars represent standard deviation of the mean. (See Supplemental Figure 1A – D for mean fluorescence intensity representations of the data from main Figure 2A – D ). E. 1 × 10 5 B16-OVA B16-OVA-(scrambled shRNA), B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) cells, pre-treated for 24 hours with 50 U of rIFN-γ, were co-cultured with 4 – 5 days in vitro activated OT-I <t>CD8</t> + T cells at an Effector:Target ratio of 1:1 in 96-well ELISPOT plates (3 biological triplicates) for 48 hours at 37°C. OVA-specific IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. F/G. The experiment of E. above was repeated with 4 – 5 days in vitro activated PMEL CD8 + T cells ( F ) or Tumor Experienced CD8 + T cells (T cells recovered from mice which had rejected B16-TK tumors in a CD8 + T cell dependent mechanism) ( G ) instead of OT-I T cells. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. H. 1 × 10 6 B16-OVA cells, pre-treated for 24 hours with 50 U of rIFN-γ, were co-cultured with 4 – 5 days in vitro activated OT-I or PMEL CD8 + T cells at an Effector:Target ratio of 10:1 (3 biological triplicates) for 21 days at 37°C. Surviving B16-OVA cells were pooled and expanded for 2 weeks in vitro to give B16-OVA-OT-I-ESC or B16-OVA-PMEL-ESC populations. qrtPCR for levels of AIRE expression in B16-OVA, B16-OVA-OT-I-ESC or B16-OVA-PMEL-ESC cells are shown. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. Ordinary one-way ANOVA statistical tests were used to analyze A-H (α=0.05).
    Macs Cd8α Ly 2 Microbead Magnetic Cell Sorting System, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+microbeads/CD8a+(Ly-2)+MicroBeads%2C+mouse/pmc13737429-58-10-18
    Average 96 stars, based on 1 article reviews
    macs cd8α ly 2 microbead magnetic cell sorting system - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec t cells
    A. Flow cytometry of B16-F10, B16-(AIRE-KO), and B16-(AIRE) tumor cells labelled with the AF6-88.5 antibody which recognizes the H-2K b MHC class I molecule. Mean values represent %H-2K b+ of three separate biological triplicates and error bars represent standard deviation of the mean. B. Flow cytometry of B16-OVA, B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) tumor cells labelled with the 25-D1.16 antibody which recognizes the H-2K b MHC class I molecule bound to the OVA-derived peptide SIINFEKL (K b -SIINFEKL). (See Supplemental Figure 1E for gating scheme). Mean values represent %H-2K b -SIINFEKL + of three separate biological triplicates and error bars represent standard deviation of the mean. C/D. The experiment of B. was repeated with the B16-OVA, B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) tumor cells being pre-treated for 24 hours with 50 U of rIFN-γ (to increase surface expression of H-2K b MHC class I molecules) ( C ) or with 50 U of rIFN-γ and 1 μg/mL of SIINFEKL peptide ( D ) prior to quantification of surface-expressed H-2K b -SIINFEKL by flow cytometry. Mean values represent %H-2K b -SIINFEKL + of three separate biological triplicates and error bars represent standard deviation of the mean. (See Supplemental Figure 1A – D for mean fluorescence intensity representations of the data from main Figure 2A – D ). E. 1 × 10 5 B16-OVA B16-OVA-(scrambled shRNA), B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) cells, pre-treated for 24 hours with 50 U of rIFN-γ, were co-cultured with 4 – 5 days in vitro activated OT-I <t>CD8</t> + T cells at an Effector:Target ratio of 1:1 in 96-well ELISPOT plates (3 biological triplicates) for 48 hours at 37°C. OVA-specific IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. F/G. The experiment of E. above was repeated with 4 – 5 days in vitro activated PMEL CD8 + T cells ( F ) or Tumor Experienced CD8 + T cells (T cells recovered from mice which had rejected B16-TK tumors in a CD8 + T cell dependent mechanism) ( G ) instead of OT-I T cells. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. H. 1 × 10 6 B16-OVA cells, pre-treated for 24 hours with 50 U of rIFN-γ, were co-cultured with 4 – 5 days in vitro activated OT-I or PMEL CD8 + T cells at an Effector:Target ratio of 10:1 (3 biological triplicates) for 21 days at 37°C. Surviving B16-OVA cells were pooled and expanded for 2 weeks in vitro to give B16-OVA-OT-I-ESC or B16-OVA-PMEL-ESC populations. qrtPCR for levels of AIRE expression in B16-OVA, B16-OVA-OT-I-ESC or B16-OVA-PMEL-ESC cells are shown. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. Ordinary one-way ANOVA statistical tests were used to analyze A-H (α=0.05).
    T Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+microbeads/CD8a+(Ly-2)+MicroBeads%2C+mouse/bio_rxiv__64898__2026__10__30__763208-340-5-10
    Average 96 stars, based on 1 article reviews
    t cells - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd8a microbeads

    Cd8a Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+microbeads/CD8a+(Ly-2)+MicroBeads%2C+mouse/pmc13755957-603-9-11
    Average 96 stars, based on 1 article reviews
    cd8a microbeads - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd8a ly 2 microbeads

    Cd8a Ly 2 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+microbeads/CD8a+(Ly-2)+MicroBeads%2C+mouse/pmc13756545-60-10-16
    Average 96 stars, based on 1 article reviews
    cd8a ly 2 microbeads - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd8a positive selection kit

    Cd8a Positive Selection Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+microbeads/CD8a+(Ly-2)+MicroBeads%2C+mouse/pm42462537-148-17-21
    Average 96 stars, based on 1 article reviews
    cd8a positive selection kit - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec anti mouse cd8 microbead miltenyi biotec

    Anti Mouse Cd8 Microbead Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+microbeads/CD8a+(Ly-2)+MicroBeads%2C+mouse/pm42341754-218-20-23
    Average 96 stars, based on 1 article reviews
    anti mouse cd8 microbead miltenyi biotec - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec human fcr blocking

    Human Fcr Blocking, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+microbeads/CD8a+(Ly-2)+MicroBeads%2C+mouse/pm42337052-182-4-16
    Average 96 stars, based on 1 article reviews
    human fcr blocking - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Senescence-associated GZMK⁺CD8⁺ T cells exhibit significant interactions with SS acinar cells. (A) UMAP plot showing the re-annotation and subclassification of T/NK cell populations into 14 distinct subsets from labial gland samples. (B) Bar graph displaying the proportional composition of T cell subsets in young and elderly SS patients and age- and sex-matched HCs, highlighting the increased proportion of GZMK⁺CD8⁺ T cells in SS patients. (C) The key markers associated with different T cell subsets in SS and HC groups. (D) Boxplot showing the proportion of GZMK⁺CD8⁺ T cells in the young and elderly SS groups compared to young and elderly HC groups, with the highest abundance observed in the elderly SS group. (E) Volcano plot of DEGs in GZMK⁺CD8⁺ T cells from SS patients compared to HCs, showing significantly upregulated functional genes in SS. (F) Boxplots showing the expression levels of GZMK in GZMK⁺CD8⁺ T cells from young and elderly SS patients and HCs, with significantly higher expression in SS groups, especially in the elderly SS group. (G) CellChat analysis of intercellular communication between GZMK⁺CD8⁺ T cells and various resident tissue cell types in labial glands, highlighting significant interactions with acinar cells. (H) Top 15 ligand-receptor pairs involved in the interaction between GZMK⁺CD8⁺ T cells and acinar cells, demonstrating the close communication between these cell types.

    Journal: International Journal of Biological Sciences

    Article Title: GZMK⁺CD8⁺ T Cells Induce Acinar Cell Senescence and Salivary Secretion Impairment in Sjögren's Syndrome via Mitochondrial Dysfunction and TMEM16A Chloride Channel Disruption

    doi: 10.7150/ijbs.134478

    Figure Lengend Snippet: Senescence-associated GZMK⁺CD8⁺ T cells exhibit significant interactions with SS acinar cells. (A) UMAP plot showing the re-annotation and subclassification of T/NK cell populations into 14 distinct subsets from labial gland samples. (B) Bar graph displaying the proportional composition of T cell subsets in young and elderly SS patients and age- and sex-matched HCs, highlighting the increased proportion of GZMK⁺CD8⁺ T cells in SS patients. (C) The key markers associated with different T cell subsets in SS and HC groups. (D) Boxplot showing the proportion of GZMK⁺CD8⁺ T cells in the young and elderly SS groups compared to young and elderly HC groups, with the highest abundance observed in the elderly SS group. (E) Volcano plot of DEGs in GZMK⁺CD8⁺ T cells from SS patients compared to HCs, showing significantly upregulated functional genes in SS. (F) Boxplots showing the expression levels of GZMK in GZMK⁺CD8⁺ T cells from young and elderly SS patients and HCs, with significantly higher expression in SS groups, especially in the elderly SS group. (G) CellChat analysis of intercellular communication between GZMK⁺CD8⁺ T cells and various resident tissue cell types in labial glands, highlighting significant interactions with acinar cells. (H) Top 15 ligand-receptor pairs involved in the interaction between GZMK⁺CD8⁺ T cells and acinar cells, demonstrating the close communication between these cell types.

    Article Snippet: CD8+ T cells were purified by positive selection using rat CD8a MicroBeads (130-090-318, Miltenyi Biotec, Germany) according to the manufacturer's instructions.

    Techniques: Functional Assay, Expressing, Analysis, Tissue, Single Cell RNA-Seq

    A. Flow cytometry of B16-F10, B16-(AIRE-KO), and B16-(AIRE) tumor cells labelled with the AF6-88.5 antibody which recognizes the H-2K b MHC class I molecule. Mean values represent %H-2K b+ of three separate biological triplicates and error bars represent standard deviation of the mean. B. Flow cytometry of B16-OVA, B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) tumor cells labelled with the 25-D1.16 antibody which recognizes the H-2K b MHC class I molecule bound to the OVA-derived peptide SIINFEKL (K b -SIINFEKL). (See Supplemental Figure 1E for gating scheme). Mean values represent %H-2K b -SIINFEKL + of three separate biological triplicates and error bars represent standard deviation of the mean. C/D. The experiment of B. was repeated with the B16-OVA, B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) tumor cells being pre-treated for 24 hours with 50 U of rIFN-γ (to increase surface expression of H-2K b MHC class I molecules) ( C ) or with 50 U of rIFN-γ and 1 μg/mL of SIINFEKL peptide ( D ) prior to quantification of surface-expressed H-2K b -SIINFEKL by flow cytometry. Mean values represent %H-2K b -SIINFEKL + of three separate biological triplicates and error bars represent standard deviation of the mean. (See Supplemental Figure 1A – D for mean fluorescence intensity representations of the data from main Figure 2A – D ). E. 1 × 10 5 B16-OVA B16-OVA-(scrambled shRNA), B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) cells, pre-treated for 24 hours with 50 U of rIFN-γ, were co-cultured with 4 – 5 days in vitro activated OT-I CD8 + T cells at an Effector:Target ratio of 1:1 in 96-well ELISPOT plates (3 biological triplicates) for 48 hours at 37°C. OVA-specific IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. F/G. The experiment of E. above was repeated with 4 – 5 days in vitro activated PMEL CD8 + T cells ( F ) or Tumor Experienced CD8 + T cells (T cells recovered from mice which had rejected B16-TK tumors in a CD8 + T cell dependent mechanism) ( G ) instead of OT-I T cells. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. H. 1 × 10 6 B16-OVA cells, pre-treated for 24 hours with 50 U of rIFN-γ, were co-cultured with 4 – 5 days in vitro activated OT-I or PMEL CD8 + T cells at an Effector:Target ratio of 10:1 (3 biological triplicates) for 21 days at 37°C. Surviving B16-OVA cells were pooled and expanded for 2 weeks in vitro to give B16-OVA-OT-I-ESC or B16-OVA-PMEL-ESC populations. qrtPCR for levels of AIRE expression in B16-OVA, B16-OVA-OT-I-ESC or B16-OVA-PMEL-ESC cells are shown. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. Ordinary one-way ANOVA statistical tests were used to analyze A-H (α=0.05).

    Journal: Cancer immunology research

    Article Title: Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome

    doi: 10.1158/2326-6066.CIR-25-1589

    Figure Lengend Snippet: A. Flow cytometry of B16-F10, B16-(AIRE-KO), and B16-(AIRE) tumor cells labelled with the AF6-88.5 antibody which recognizes the H-2K b MHC class I molecule. Mean values represent %H-2K b+ of three separate biological triplicates and error bars represent standard deviation of the mean. B. Flow cytometry of B16-OVA, B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) tumor cells labelled with the 25-D1.16 antibody which recognizes the H-2K b MHC class I molecule bound to the OVA-derived peptide SIINFEKL (K b -SIINFEKL). (See Supplemental Figure 1E for gating scheme). Mean values represent %H-2K b -SIINFEKL + of three separate biological triplicates and error bars represent standard deviation of the mean. C/D. The experiment of B. was repeated with the B16-OVA, B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) tumor cells being pre-treated for 24 hours with 50 U of rIFN-γ (to increase surface expression of H-2K b MHC class I molecules) ( C ) or with 50 U of rIFN-γ and 1 μg/mL of SIINFEKL peptide ( D ) prior to quantification of surface-expressed H-2K b -SIINFEKL by flow cytometry. Mean values represent %H-2K b -SIINFEKL + of three separate biological triplicates and error bars represent standard deviation of the mean. (See Supplemental Figure 1A – D for mean fluorescence intensity representations of the data from main Figure 2A – D ). E. 1 × 10 5 B16-OVA B16-OVA-(scrambled shRNA), B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) cells, pre-treated for 24 hours with 50 U of rIFN-γ, were co-cultured with 4 – 5 days in vitro activated OT-I CD8 + T cells at an Effector:Target ratio of 1:1 in 96-well ELISPOT plates (3 biological triplicates) for 48 hours at 37°C. OVA-specific IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. F/G. The experiment of E. above was repeated with 4 – 5 days in vitro activated PMEL CD8 + T cells ( F ) or Tumor Experienced CD8 + T cells (T cells recovered from mice which had rejected B16-TK tumors in a CD8 + T cell dependent mechanism) ( G ) instead of OT-I T cells. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. H. 1 × 10 6 B16-OVA cells, pre-treated for 24 hours with 50 U of rIFN-γ, were co-cultured with 4 – 5 days in vitro activated OT-I or PMEL CD8 + T cells at an Effector:Target ratio of 10:1 (3 biological triplicates) for 21 days at 37°C. Surviving B16-OVA cells were pooled and expanded for 2 weeks in vitro to give B16-OVA-OT-I-ESC or B16-OVA-PMEL-ESC populations. qrtPCR for levels of AIRE expression in B16-OVA, B16-OVA-OT-I-ESC or B16-OVA-PMEL-ESC cells are shown. Mean values are shown for three separate biological triplicates and error bars represent standard deviation of the mean. Ordinary one-way ANOVA statistical tests were used to analyze A-H (α=0.05).

    Article Snippet: When indicated, CD8 + T cells were isolated using the MACS CD8α (Ly-2) Microbead magnetic cell sorting system (Miltenyi Biotec; Cat# 130-117-044) and stained with CFSE dye (Invitrogen; Cat# C34554 ) according to the manufacturers’ instructions.

    Techniques: Flow Cytometry, Standard Deviation, shRNA, Derivative Assay, Expressing, Fluorescence, Cell Culture, In Vitro, Enzyme-linked Immunospot

    A/B. C57BL/6 mice with 10 day-established subcutaneous B16-OVA, B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) tumors (n=8 mice per group) were treated intravenously with 1 × 10 7 naïve OT-I ( A ) or PMEL ( B ) CD8 + T cells. 2 days later (d12), mice were treated with VSV-OVA, VSV-hgp100 or VSV-GFP as shown (5 × 10 6 pfu virus/injection, i.v.). This cycle of adoptive T cell transfer and virus boost was repeated on days 14 and 17 and 19 and 21. Tumor diameters were measured thrice weekly in two dimensions using calipers, and mice were sacrificed when tumor size was ~1.0 × 1.0 cm in two perpendicular directions. Survival and tumor volume with time are shown. C. C57BL/6 mice with 10 day-established B16-F10, B16-F10-(shRNA-AIRE) or B16-F10-(AIRE) tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with lysates of PBS (no lysate) B16-F10-(shRNA-AIRE) or B16-F10-(AIRE) cells (1 × 10 6 DC loaded with lysate equivalent of 1 × 10 7 tumor cells per injection) (see Materials and Methods ) on days 10,12 & 14. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 17, 19, 21 and 24, 26 & 28. Survival and tumor volume with time are shown. D. CD8 + T cells (1 × 10 6 /well) were isolated from mice at endpoint in C (4/group) (see Materials and Methods ) which had been treated with DC vaccines loaded with lysates of B16-F10, B16-F10-(shRNA-AIRE) or B16-F10-(AIRE) and co-treated with anti-PD-1 or control IgG, as shown. CD8 + T cells were re-stimulated in 96-well ELISPOT plates (4 biological triplicates) with 5 × 10 5 live target cells (B16-F10, B16-F10-(AIRE) or CT2A (pre-treated with IFN-γ for 24 hours to increase MHC class I expression) for 48 hours at 37°C. Tumor-specific IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for four biological triplicates and error bars represent standard deviation of the mean. Gehan-Breslow-Wilcoxon statistical tests for survival were used for A-C , and ordinary one-way ANOVA statistical tests were used to analyze D (α=0.05).

    Journal: Cancer immunology research

    Article Title: Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome

    doi: 10.1158/2326-6066.CIR-25-1589

    Figure Lengend Snippet: A/B. C57BL/6 mice with 10 day-established subcutaneous B16-OVA, B16-OVA-(shRNA-AIRE) or B16-OVA-(AIRE) tumors (n=8 mice per group) were treated intravenously with 1 × 10 7 naïve OT-I ( A ) or PMEL ( B ) CD8 + T cells. 2 days later (d12), mice were treated with VSV-OVA, VSV-hgp100 or VSV-GFP as shown (5 × 10 6 pfu virus/injection, i.v.). This cycle of adoptive T cell transfer and virus boost was repeated on days 14 and 17 and 19 and 21. Tumor diameters were measured thrice weekly in two dimensions using calipers, and mice were sacrificed when tumor size was ~1.0 × 1.0 cm in two perpendicular directions. Survival and tumor volume with time are shown. C. C57BL/6 mice with 10 day-established B16-F10, B16-F10-(shRNA-AIRE) or B16-F10-(AIRE) tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with lysates of PBS (no lysate) B16-F10-(shRNA-AIRE) or B16-F10-(AIRE) cells (1 × 10 6 DC loaded with lysate equivalent of 1 × 10 7 tumor cells per injection) (see Materials and Methods ) on days 10,12 & 14. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 17, 19, 21 and 24, 26 & 28. Survival and tumor volume with time are shown. D. CD8 + T cells (1 × 10 6 /well) were isolated from mice at endpoint in C (4/group) (see Materials and Methods ) which had been treated with DC vaccines loaded with lysates of B16-F10, B16-F10-(shRNA-AIRE) or B16-F10-(AIRE) and co-treated with anti-PD-1 or control IgG, as shown. CD8 + T cells were re-stimulated in 96-well ELISPOT plates (4 biological triplicates) with 5 × 10 5 live target cells (B16-F10, B16-F10-(AIRE) or CT2A (pre-treated with IFN-γ for 24 hours to increase MHC class I expression) for 48 hours at 37°C. Tumor-specific IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for four biological triplicates and error bars represent standard deviation of the mean. Gehan-Breslow-Wilcoxon statistical tests for survival were used for A-C , and ordinary one-way ANOVA statistical tests were used to analyze D (α=0.05).

    Article Snippet: When indicated, CD8 + T cells were isolated using the MACS CD8α (Ly-2) Microbead magnetic cell sorting system (Miltenyi Biotec; Cat# 130-117-044) and stained with CFSE dye (Invitrogen; Cat# C34554 ) according to the manufacturers’ instructions.

    Techniques: shRNA, Virus, Injection, In Vitro, Control, Isolation, Vaccines, Enzyme-linked Immunospot, Expressing, Standard Deviation

    A. C57BL/6 mice with 7 day-established subcutaneous B16-F10 tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with lysates of PBS (no lysate) B16-F10 or B16-F10-(AIRE) cells (1 × 10 6 DC loaded with lysate equivalent of 1 × 10 7 tumor cells per injection) (see Materials and Methods ) on days 7, 9 & 11. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 14, 16, and 18. Tumors were harvested at day 20 and processed for CyTOF analysis. Schematic created in BioRender. Kendall, B. (2026) https://BioRender.com/twjnrsd . B. Live CD45 + cells were analyzed using the CATALYST R pipeline (see Materials and Methods ), and immune cell clusters were identified by unsupervised FlowSOM/ConsensusClusterPlus clustering and subsequently manually annotated. Heatmap depicts median scaled expression of phenotypic markers stratified by cluster. C. t-Distributed Stochastic Neighbor Embedding (tSNE) plots of tumor-infiltrating CD45 + cells (n=4). D. Relative immune cell subset abundance by experimental condition. Lines of the box and whisker plots represent the lower quartile, median, and upper quartile of the dataset. E. Bar graph showing the frequency of CD4 + or CD8 + T cells among live CD45 + TILs (n=4). F-G. Bar graphs showing frequency of CD8 + T cells expressing markers of ( F ) T cell activation, exhaustion, and ( G ) memory phenotype (n=4). Error bars indicate standard error of the means (SEM). P-values were determined using a one-way ANOVA with a Tukey multiple-comparison posttest. * p <0.05, ** <0.01, *** <0.001, and **** <0.0001.

    Journal: Cancer immunology research

    Article Title: Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome

    doi: 10.1158/2326-6066.CIR-25-1589

    Figure Lengend Snippet: A. C57BL/6 mice with 7 day-established subcutaneous B16-F10 tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with lysates of PBS (no lysate) B16-F10 or B16-F10-(AIRE) cells (1 × 10 6 DC loaded with lysate equivalent of 1 × 10 7 tumor cells per injection) (see Materials and Methods ) on days 7, 9 & 11. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 14, 16, and 18. Tumors were harvested at day 20 and processed for CyTOF analysis. Schematic created in BioRender. Kendall, B. (2026) https://BioRender.com/twjnrsd . B. Live CD45 + cells were analyzed using the CATALYST R pipeline (see Materials and Methods ), and immune cell clusters were identified by unsupervised FlowSOM/ConsensusClusterPlus clustering and subsequently manually annotated. Heatmap depicts median scaled expression of phenotypic markers stratified by cluster. C. t-Distributed Stochastic Neighbor Embedding (tSNE) plots of tumor-infiltrating CD45 + cells (n=4). D. Relative immune cell subset abundance by experimental condition. Lines of the box and whisker plots represent the lower quartile, median, and upper quartile of the dataset. E. Bar graph showing the frequency of CD4 + or CD8 + T cells among live CD45 + TILs (n=4). F-G. Bar graphs showing frequency of CD8 + T cells expressing markers of ( F ) T cell activation, exhaustion, and ( G ) memory phenotype (n=4). Error bars indicate standard error of the means (SEM). P-values were determined using a one-way ANOVA with a Tukey multiple-comparison posttest. * p <0.05, ** <0.01, *** <0.001, and **** <0.0001.

    Article Snippet: When indicated, CD8 + T cells were isolated using the MACS CD8α (Ly-2) Microbead magnetic cell sorting system (Miltenyi Biotec; Cat# 130-117-044) and stained with CFSE dye (Invitrogen; Cat# C34554 ) according to the manufacturers’ instructions.

    Techniques: In Vitro, Injection, Control, Analysis, Immune Cell, Expressing, Whisker Assay, Activation Assay, Comparison

    A. Schematic of AAV-8-AIRE and AAV-8-GFP vectors (Created in BioRender. Chen, A. (2026) https://BioRender.com/lwpmjbq ). B. HEK 293T cells were transduced with AAV-8-AIRE (lane 2) or AAV-8-GFP (lane 3) at 5 × 10 5 genome copies/cell. 72 hours later, cells were harvested and assayed by Western Blot for AIRE (FLAG) and β-Actin. B16-F10 cells were transduced with AAV-8-AIRE at 7 × 10 5 genome copies/cell and stained 72 hours later for immunofluorescence for AIRE (FLAG). C/D. 5 day-established B16-F10 subcutaneous tumors (of n=8 mice per group) were injected in three cycles EARLY 5, 7, 9; MIDDLE 12, 14, 16; and LATE 19, 21, 23 with either virus (AAV-8-AIRE or AAV-8-GFP) or with anti-PD-1 ICB antibody or control IgG antibody (200 μg/injection) ( C ). When tumors reached an endpoint of 1.0 cm tumor diameter in any direction, mice were euthanized (Created in BioRender. Chen, A. (2026) https://BioRender.com/9952k6n ). Survival and tumor volume by time are shown ( D ). E. Spleens were recovered from the first 3 mice in each group to be euthanized. CD8 + T cells were isolated by magnetic bead sorting and co-cultured at an Effector:Target ratio of 5:1 in 96-well ELISPOT plates with live target B16-F10 cells, pre-treated for 24 hours with IFN-γ to increase MHC Class I expression for 48 hours at 37°C. B16-F10-specific IFN-γ ELISPOT positive spots from the supernatants were quantified by a computer assisted image analyzer ( i ) and levels of IFN-γ were measured from the supernatants by ELISA ( ii ) (three biological replicates per group). Mean values are shown for three biological replicates and error bars represent standard deviation of the mean. F. 5 day-established B16-F10 subcutaneous tumors (of n=8 mice per group) were injected intra-tumorally on days 5, 7, 12, 14, 16 with PBS or virus (AAV-8-AIRE or AAV-8-GFP) and with control IgG antibody or depleting antibody (anti-CD4, anti-CD8 or anti-NK) (200 μg/injection ip) on days 5, 7, 12 & 14. When tumors reached an endpoint of 1.0 cm tumor diameter in any direction, mice were euthanized and survival and tumor volume with time are shown. Note that the NK cell depletion group is obscured by the AAV-8-AIRE / AAV-8-AIRE / IgG group as they follow the same survival curve. Gehan-Breslow-Wilcoxon statistical tests for survival were used for D & F , and ordinary one-way ANOVA statistical tests were used to analyze E (α=0.05).

    Journal: Cancer immunology research

    Article Title: Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome

    doi: 10.1158/2326-6066.CIR-25-1589

    Figure Lengend Snippet: A. Schematic of AAV-8-AIRE and AAV-8-GFP vectors (Created in BioRender. Chen, A. (2026) https://BioRender.com/lwpmjbq ). B. HEK 293T cells were transduced with AAV-8-AIRE (lane 2) or AAV-8-GFP (lane 3) at 5 × 10 5 genome copies/cell. 72 hours later, cells were harvested and assayed by Western Blot for AIRE (FLAG) and β-Actin. B16-F10 cells were transduced with AAV-8-AIRE at 7 × 10 5 genome copies/cell and stained 72 hours later for immunofluorescence for AIRE (FLAG). C/D. 5 day-established B16-F10 subcutaneous tumors (of n=8 mice per group) were injected in three cycles EARLY 5, 7, 9; MIDDLE 12, 14, 16; and LATE 19, 21, 23 with either virus (AAV-8-AIRE or AAV-8-GFP) or with anti-PD-1 ICB antibody or control IgG antibody (200 μg/injection) ( C ). When tumors reached an endpoint of 1.0 cm tumor diameter in any direction, mice were euthanized (Created in BioRender. Chen, A. (2026) https://BioRender.com/9952k6n ). Survival and tumor volume by time are shown ( D ). E. Spleens were recovered from the first 3 mice in each group to be euthanized. CD8 + T cells were isolated by magnetic bead sorting and co-cultured at an Effector:Target ratio of 5:1 in 96-well ELISPOT plates with live target B16-F10 cells, pre-treated for 24 hours with IFN-γ to increase MHC Class I expression for 48 hours at 37°C. B16-F10-specific IFN-γ ELISPOT positive spots from the supernatants were quantified by a computer assisted image analyzer ( i ) and levels of IFN-γ were measured from the supernatants by ELISA ( ii ) (three biological replicates per group). Mean values are shown for three biological replicates and error bars represent standard deviation of the mean. F. 5 day-established B16-F10 subcutaneous tumors (of n=8 mice per group) were injected intra-tumorally on days 5, 7, 12, 14, 16 with PBS or virus (AAV-8-AIRE or AAV-8-GFP) and with control IgG antibody or depleting antibody (anti-CD4, anti-CD8 or anti-NK) (200 μg/injection ip) on days 5, 7, 12 & 14. When tumors reached an endpoint of 1.0 cm tumor diameter in any direction, mice were euthanized and survival and tumor volume with time are shown. Note that the NK cell depletion group is obscured by the AAV-8-AIRE / AAV-8-AIRE / IgG group as they follow the same survival curve. Gehan-Breslow-Wilcoxon statistical tests for survival were used for D & F , and ordinary one-way ANOVA statistical tests were used to analyze E (α=0.05).

    Article Snippet: When indicated, CD8 + T cells were isolated using the MACS CD8α (Ly-2) Microbead magnetic cell sorting system (Miltenyi Biotec; Cat# 130-117-044) and stained with CFSE dye (Invitrogen; Cat# C34554 ) according to the manufacturers’ instructions.

    Techniques: In Vivo, Transduction, Western Blot, Staining, Immunofluorescence, Injection, Virus, Control, Isolation, Cell Culture, Enzyme-linked Immunospot, Expressing, Enzyme-linked Immunosorbent Assay, Standard Deviation

    A. Schematic for MHC Class I immunoprecipitation from B16-F10, B16-(shRNA-AIRE), and B16-F10-(AIRE) cells using the Clone Y-3 anti-H-2K b antibody (Created in BioRender. Chen, A. (2026) https://BioRender.com/grw7tkh ). B. C57BL/6 mice with 5 day-established B16-F10 tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with SIINFEKL peptide (1 μg per 1 × 10 6 DC/injection) with PBS or with peptide sets of the Unique, Shared, Longer peptides (see Table 1 ) (at 0.25 μg per peptide, total 1 μg per 1 × 10 6 DC/injection) on days 5, 7 & 9. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 12, 14, 16 and 19, 21, 23. For clarity, survival and tumor volume with time are shown for groups treated with control IgG (no ICB) ( B ) or with ICB ( C ) ( B & C are the same experiment). D. CD8 + T cells (1 × 10 6 /well) were isolated from mice at endpoint in B/C. (4/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 1 × 10 6 CD8 + T cells were re-stimulated in 96-well ELISPOT plates (4 biological triplicates shown) with either 5 × 10 5 live target cells (B16-F10 or B16-F10-(AIRE) (pre-treated with IFN-γ for 24 hours to increase MHC class I expression) or with either 5 × 10 5 dendritic cells loaded with the Unique, Shared, Longer peptide sets or SIINFEKL peptide (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for four biological triplicates and error bars represent standard deviation of the mean. E. CD4 + T cells were isolated by magnetic bead sorting from mice at endpoint in B/C (3/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 5 × 10 5 CD4 + T cells were re-stimulated in 96-well plates (3 biological triplicates shown) with 5 × 10 5 dendritic cells loaded with the Longer ( i ), Shared ( ii ), or Unique ( iii ) peptide sets (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. 48 hours later IL-15 in the supernatant was measured by ELISA (Bio-Techne, R&D Systems; Mouse IL-15 DuoSet ELISA; Cat# DY447). Mean values are shown for three biological triplicates and error bars represent standard deviation of the mean. Gehan-Breslow-Wilcoxon statistical tests for survival were used for B & C , and ordinary one-way ANOVA statistical tests were used to analyze D & E (α=0.05).

    Journal: Cancer immunology research

    Article Title: Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome

    doi: 10.1158/2326-6066.CIR-25-1589

    Figure Lengend Snippet: A. Schematic for MHC Class I immunoprecipitation from B16-F10, B16-(shRNA-AIRE), and B16-F10-(AIRE) cells using the Clone Y-3 anti-H-2K b antibody (Created in BioRender. Chen, A. (2026) https://BioRender.com/grw7tkh ). B. C57BL/6 mice with 5 day-established B16-F10 tumors (n=8 mice per group) were treated with dendritic cells loaded in vitro with SIINFEKL peptide (1 μg per 1 × 10 6 DC/injection) with PBS or with peptide sets of the Unique, Shared, Longer peptides (see Table 1 ) (at 0.25 μg per peptide, total 1 μg per 1 × 10 6 DC/injection) on days 5, 7 & 9. Mice were then treated with anti-PD-1 antibody or isotype IgG control as shown on days 12, 14, 16 and 19, 21, 23. For clarity, survival and tumor volume with time are shown for groups treated with control IgG (no ICB) ( B ) or with ICB ( C ) ( B & C are the same experiment). D. CD8 + T cells (1 × 10 6 /well) were isolated from mice at endpoint in B/C. (4/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 1 × 10 6 CD8 + T cells were re-stimulated in 96-well ELISPOT plates (4 biological triplicates shown) with either 5 × 10 5 live target cells (B16-F10 or B16-F10-(AIRE) (pre-treated with IFN-γ for 24 hours to increase MHC class I expression) or with either 5 × 10 5 dendritic cells loaded with the Unique, Shared, Longer peptide sets or SIINFEKL peptide (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. IFN-γ positive spots were quantified by computer assisted image analyzer. Mean values are shown for four biological triplicates and error bars represent standard deviation of the mean. E. CD4 + T cells were isolated by magnetic bead sorting from mice at endpoint in B/C (3/group) which had been treated with DC vaccines loaded with different peptides and co-treated with anti-PD-1 as shown. 5 × 10 5 CD4 + T cells were re-stimulated in 96-well plates (3 biological triplicates shown) with 5 × 10 5 dendritic cells loaded with the Longer ( i ), Shared ( ii ), or Unique ( iii ) peptide sets (total of 1 μg peptide/10 6 DC) for 48 hours at 37°C. 48 hours later IL-15 in the supernatant was measured by ELISA (Bio-Techne, R&D Systems; Mouse IL-15 DuoSet ELISA; Cat# DY447). Mean values are shown for three biological triplicates and error bars represent standard deviation of the mean. Gehan-Breslow-Wilcoxon statistical tests for survival were used for B & C , and ordinary one-way ANOVA statistical tests were used to analyze D & E (α=0.05).

    Article Snippet: When indicated, CD8 + T cells were isolated using the MACS CD8α (Ly-2) Microbead magnetic cell sorting system (Miltenyi Biotec; Cat# 130-117-044) and stained with CFSE dye (Invitrogen; Cat# C34554 ) according to the manufacturers’ instructions.

    Techniques: Over Expression, Immunoprecipitation, shRNA, In Vitro, Injection, Control, Isolation, Vaccines, Enzyme-linked Immunospot, Expressing, Standard Deviation, 96 Well Plates, Enzyme-linked Immunosorbent Assay, Liquid Chromatography with Mass Spectroscopy, Tandem Mass Spectroscopy

    Journal: iScience

    Article Title: Nemo-like kinase limits T cell activation while preserving anti-tumor responses

    doi: 10.1016/j.isci.2026.118070

    Figure Lengend Snippet:

    Article Snippet: CD8 + cells were isolated via positive selection using CD8a microbeads (Miltenyi Biotec; 130–117-044).

    Techniques: Cell Isolation